Mascoma Wealth Management’s GSK GSK Stock Holding History

Mascoma Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$944	Buy	+18	New	+$952	﹤0.01%	512
2022 Q4	–	Sell	-292	Closed	-$9.73K	–	642
2022 Q3	$9K	Hold	292	–	–	﹤0.01%	414
2022 Q2	$16K	Hold	292	–	–	0.01%	367
2022 Q1	$16K	Hold	292	–	–	0.01%	392
2021 Q4	$16K	Hold	292	–	–	0.01%	356
2021 Q3	$14K	Buy	+292	New	+$14.7K	0.01%	320
2021 Q2	–	Sell	-292	Closed	-$13K	–	247
2021 Q1	$13K	Buy	+292	New	+$13.3K	0.01%	325
2019 Q3	–	Sell	-482	Closed	-$24K	–	191
2019 Q2	$24K	Hold	482	–	–	0.02%	216
2019 Q1	$25K	Sell	482 -460	-49%	-$23K	0.02%	207
2018 Q4	$45K	Sell	942 -260	-22%	-$12.8K	0.03%	147
2018 Q3	$60K	Sell	1,202 -100	-8%	-$5.08K	0.04%	151
2018 Q2	$66K	Hold	1,302	–	–	0.05%	135
2018 Q1	$64K	Sell	1,302 -768	-37%	-$35.8K	0.04%	133
2017 Q4	$96K	Sell	2,070 -1,712	-45%	-$79.1K	0.06%	112
2017 Q3	$192K	Hold	3,782	–	–	0.13%	75
2017 Q2	$204K	Sell	3,782 -160	-4%	-$8.53K	0.14%	71
2017 Q1	$208K	Sell	3,942 -104	-3%	-$5.28K	0.15%	59
2016 Q4	$195K	Buy	+4,046	New	+$200K	0.14%	65

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mascoma Wealth Management's GSK Position: Q2 2026 in Review

Mascoma Wealth Management opened a new position in GSK (GSK) in Q2 2026: 18 shares worth $944. The stake represents ﹤0.01% of the portfolio and ranks #512 among its holdings. This is a return to the name: Mascoma Wealth Management previously reported a position in GSK as recently as Q3 2022.

Mascoma Wealth Management first reported a position in GSK in Q4 2016 and has held it in 18 quarters since. The position peaked at $208K in Q1 2017. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Mascoma Wealth Management held 18 shares of GSK worth $944 as of Q2 2026.
GSK was a new Mascoma Wealth Management position in Q2 2026.
GSK made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #512 holding.
Mascoma Wealth Management first reported a position in GSK in Q4 2016 and has held it in 18 quarters since.
Mascoma Wealth Management's GSK position peaked at $208K in Q1 2017.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.